Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Vopr Onkol1
Search Results
Sort by
- BookDieter Schmidt, Emeritus Professor of Neurology, ... Show More Free University Berlin and Head of Epilepsy Research Group Berlin, Germany, Simon Shorvon, Professor of Neurology, Institute of Neurology, University College London, and Consultant Neurologist National Hospital for Neurology and Neurosurgery, London, UK.Contents:
1 What is Epilepsy?
2 Attitudes
3 The Pharmaceutical Phoenix Rises
4 Modern Blockbusters
5 Resecting Epilepsy
6. The Dark Side of Epilepsy
7 Culs-de-Sac and Bureaucracies
8 Is the End of Epilepsy in Sight?
Appendix: Dating Epilepsy --Index.Digital Access Oxford 2016 - ArticleKurinenko BM, Beliaeva MI, Cherepneva IE, Kuprianova-Ashina FG.Vopr Onkol. 1977;23(5):86-90.Under study was the permeability of nuclease Ser marcescens, bound covalently by the method of diazocombinations with m-amino benzyloxymethyl-dextran of the molecular weight 20 000, 40 000, 60 000 via the vascular barrier and the membrane of tumor cells. It is shown that dextran-bound nuclease as well as the native enzyme would penetrate into the intacts cells of Ehrlich ascites carcinoma. The rate of the modified nuclease penetration is dependent on dextran molecular weight. Along with the native enzyme also nuclease bound to dextran of the molecular weight 20 000 and 40 000 penetrates the vascular barrier. The permeability of the vascular barrier for dextran-bound nuclease is found to be considerably higher in tumor-bearing animals than in intact ones.